Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00931476 · ClinicalTrials.gov registry record · Phase 1
A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin
A Phase 1 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 86
- Enrollment target
NCT00931476 is a Phase 1 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 86 participants.
The verdict
NCT00931476, a Phase 1 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 86 participants
- Enrollment target
Study Summary
This trial was conducted in the United States of America (USA). The aim of this clinical trial was to investigate the pharmacokinetics of somatropin in healthy Japanese and Caucasian subjects, and to identify somatostatin-related adverse events.
Interventions
- DRUG placebo
- DRUG somatropin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2000-04-06 |
| Est. Completion | 2000-06-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00931476
The ClinicalTrials.gov registry entry for NCT00931476 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00931476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00931476 about?
NCT00931476 is a clinical study titled "A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin". This trial was conducted in the United States of America (USA). The aim of this clinical trial was to investigate the pharmacokinetics of somatropin in healthy Japanese and Caucasian subjects, and to identify somatostatin-related adverse events.
What is the current status of trial NCT00931476?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 86 participants. The study started on 2000-04-06. Estimated completion is 2000-06-08.
What interventions are being tested in trial NCT00931476?
The interventions under investigation include: placebo (DRUG), somatropin (DRUG).
Who is sponsoring clinical trial NCT00931476?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.